Publications by authors named "Olga Ritz"

Claim this Profile
V
Validation of a Manual Protocol for BRAF V600E Mutation-specific Immunohistochemistry.
Hanns C Dinges, David Capper, Olga Ritz, Silke Brüderlein, Ralf Marienfeld

Appl Immunohistochem Mol Morphol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the intratumor heterogeneity in PMBL.
Olga Ritz, Peter Möller, Alexey Ushmorov

Cell Cycle· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knock-down of BCL6 / STAT6 sensitizes primary B cell lymphoma cells for treatment with current therapeutic agents.
Marie-Therese Häberle, Elena Kelsch, Karola Dorsch, Peter Möller, Olga Ritz

Oncoscience· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma.
Linka Xie, Olga Ritz, Frank Leithäuser, Hanfeng Guan, Johanna Färbinger

Oncotarget· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL).
Olga Ritz, Karolin Rommel, Karola Dorsch, Elena Kelsch, Julia Melzner

Oncotarget· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients.
Birgit Schif, Jochen K Lennerz, Christian W Kohler, Stefan Bentink, Markus Kreuz, Olga Ritz

Oncotarget· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.
Olga Ritz, Chrystelle Guiter, Flavia Castellano, Karola Dorsch, Julia Melzner

Blood· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target sequence accessibility limits activation-induced cytidine deaminase activity in primary mediastinal B-cell lymphoma.
Sergey W Popov, Gerhard Moldenhauer, Beate Wotschke, Silke Brüderlein, Thomas F Barth, Olga Ritz

Cancer Res· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biallelic deletion within 16p13.13 including SOCS-1 in Karpas1106P mediastinal B-cell lymphoma line is associated with delayed degradation of JAK2 protein.
Ingo Melzner, Marc A Weniger, Alexandra J Bucur, Silke Brüderlein, Karola Dorsch, Olga Ritz

Int J Cancer· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AID expression identifies interfollicular large B cells as putative precursors of mature B-cell malignancies.
Gerhard Moldenhauer, Sergey W Popov, Beate Wotschke, Silke Brüderlein, Petra Riedl, Olga Ritz

Blood· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of internal enhancer activity contributes to abnormally low immunoglobulin expression in the MedB-1 mediastinal B-cell lymphoma cell line.
Olga Ritz, Frank Leithäuser, Cornelia Hasel, Silke Brüderlein, Alexey Ushmorov

J Pathol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression.
Alexey Ushmorov, Olga Ritz, Michael Hummel, Frank Leithäuser, Peter Möller

Blood· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis